このページは機械翻訳されています。他のページは英語で表示される場合があります。 View in English

心臓病理生理学と治療開発における翻訳制御:mRNAが心臓と出会うとき

  • 0Aab Cardiovascular Research Institute, Department of Medicine, University of Rochester School of Medicine & Dentistry, Rochester, NY 14586, USA.

|

|

まとめ

この要約は機械生成です。

心臓病の転移制御を理解することは 極めて重要です このレビューは,心臓機能,疾患,心臓疾患に対する潜在的なRNAベースの治療におけるその役割を強調しています.

科学分野

  • 心血管生物学
  • 分子医学
  • 遺伝子発現の規制

背景

  • 転写に重点を置いた心臓の研究は 転写制御を無視した.
  • 重要な知識のギャップは,心疾患の病理学的影響,分子メカニズム,およびトランスレーション制御の治療の可能性にあります.
  • 変換制御 つまりmRNAからタンパク質を合成することは 心臓の機能に不可欠です

研究 の 目的

  • 心臓の健康と疾患におけるトランスレーション制御に関する最近の発見をレビューする.
  • 生理学的機能,病原性,生化学的メカニズムを要約する.
  • 心臓病に対する 潜在的RNAベースの 翻訳操作薬の探索です

主な方法

  • 心臓の転移調節を研究するテクニックの紹介
  • 翻訳制御機能とメカニズムにおける発見の要約
  • 主要な例として心臓の縮と線維症に注目してください.

主要な成果

  • 転移因子はタンパク質の産生を調節し ストレス下での心臓の改造に影響します
  • 特定の調節因子とその変化が心臓病の病因に寄与する.
  • 転写制御は転写調節,代謝,およびサルコメアホメオスタシスと相互作用する.
  • 心筋細胞の増殖と心臓の再生における役割が特定された.

結論

  • トランスクリプト特異的なタンパク質の変換調節は心臓病で起こります.
  • 標的選択型トランスレーション阻害剤と強化剤は新しい治療戦略を提供します.
  • 心臓病の治療のためのRNAベースの薬の開発は有望な道です.

関連する概念動画

Pathophysiology of Cardiac Performance 01:29

799

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...

Translational Regulation 01:29

91

Translational regulation in prokaryotes ensures efficient protein synthesis by controlling ribosome access to mRNA. This regulation is mediated by secondary RNA structures, including translational riboswitches, RNA thermometers, and small RNAs (sRNAs), which respond to intracellular and environmental signals to modulate gene expression.Translational RiboswitchesRiboswitches in the leader region of mRNAs can regulate translation by altering the accessibility of the Shine-Dalgarno (SD) sequence,...

Transducer Mechanism: Enzyme-Linked Receptors 01:27

2.8K

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:

Receptor tyrosine kinases:

Receptor tyrosine kinases (RTKs) phosphorylate specific tyrosines on the signaling proteins. RTKs include various growth factor receptors,...

Regulation of Expression Occurs at Multiple Steps 02:24

23.2K

Gene expression can be regulated at almost every step from gene to protein. Transcription is the step that is most commonly regulated. This involves the binding of proteins to short regulatory sequences on the DNA. This association can either promote or inhibit the transcription of a gene associated with the respective sequence.
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...

Cardiomyopathy V: Interprofessional Care 01:29

32

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

Heart Failure Drugs: Inotropic Agents 01:26

717

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...